Orchestra BioMed Holdings Inc. (OBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $570.61M
Last updated: Nov 17, 2026 at 11:05 AM ET
Orchestra BioMed Holdings Inc. (OBIO) Earnings: Report Dates and Results
Orchestra BioMed Holdings (OBIO) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Orchestra BioMed Holdings reported EPS of -$0.30, above the -$0.40 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OBIO has an expected report date of Mar 10, 2027.
Earnings History
Of the 16 quarters below that had an estimate, OBIO beat 11, missed 4 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $91000, down 89.4% from $861000 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.30 | -$0.40 | -$0.45 - -$0.37 | +25.00% | Beat | N/A | 6 | 1 up, 2 down | Nov 10, 2026 | $91000 |
| Jun 30, 2026 | -$0.38 | -$0.35 | -$0.41 - -$0.28 | -8.57% | Miss | N/A | 5 | 4 up, 1 down | Aug 10, 2026 | $88000 |
| Mar 31, 2026 | -$0.33 | -$0.44 | -$0.49 - -$0.39 | +25.55% | Beat | N/A | 6 | 1 up, 2 down | May 12, 2026 | $110000 |
| Dec 31, 2025 | $0.26 | -$0.38 | -$0.42 - -$0.34 | +168.42% | Beat | N/A | 7 | 1 up, 1 down | Mar 12, 2026 | $30.92M |
| Sep 30, 2025 | -$0.40 | -$0.43 | -$0.56 - -$0.35 | +6.98% | Beat | N/A | 5 | 3 up, 0 down | Nov 10, 2025 | $861000 |
| Jun 30, 2025 | -$0.50 | -$0.51 | -$0.53 - -$0.49 | +1.96% | Beat | N/A | 6 | 0 up, 2 down | Aug 12, 2025 | $836000 |
| Mar 31, 2025 | -$0.49 | -$0.48 | -$0.61 - -$0.40 | -2.08% | Miss | N/A | 6 | 2 up, 0 down | Apr 2, 2025 | $868000 |
| Dec 31, 2024 | -$0.42 | -$0.45 | N/A | +6.67% | Beat | N/A | 6 | 3 up, 0 down | Mar 26, 2025 | $253000 |
| Sep 30, 2024 | -$0.41 | -$0.44 | -$0.45 - -$0.40 | +6.82% | Beat | N/A | 4 | 0 up, 0 down | Nov 12, 2024 | $987000 |
| Jun 30, 2024 | -$0.45 | -$0.40 | -$0.42 - -$0.37 | -12.50% | Miss | N/A | 4 | 1 up, 0 down | Aug 12, 2024 | $778000 |
| Mar 31, 2024 | -$0.38 | -$0.38 | -$0.42 - -$0.38 | 0.00% | In line | N/A | 3 | 0 up, 0 down | May 13, 2024 | $620000 |
| Dec 31, 2023 | -$0.37 | -$0.38 | -$0.41 - -$0.34 | +2.63% | Beat | N/A | 2 | 0 up, 0 down | Mar 27, 2024 | $262000 |
| Sep 30, 2023 | -$0.38 | -$0.39 | -$0.42 - -$0.36 | +2.56% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2023 | $419000 |
| Jun 30, 2023 | -$0.35 | -$0.41 | N/A | +14.63% | Beat | N/A | N/A | N/A | Aug 10, 2023 | $915000 |
| Mar 31, 2023 | -$0.40 | -$0.28 | N/A | -42.86% | Miss | N/A | N/A | N/A | May 12, 2023 | $1.16M |
| Dec 31, 2022 | -$0.08 | -$1.71 | N/A | +95.32% | Beat | N/A | N/A | N/A | Jan 24, 2023 | $1.10M |
| Sep 30, 2022 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 16, 2022 | $1.16M |
| Jun 30, 2022 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 15, 2022 | $401000 |
| Mar 31, 2022 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2022 | $866000 |
| Dec 31, 2021 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2022 | N/A |
| Sep 30, 2021 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | N/A |
| Jun 30, 2021 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 16, 2021 | N/A |
| Mar 31, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2021 | N/A |
| Dec 31, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 | N/A |
| Sep 30, 2020 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Jul 17, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.13, after -$1.66 the year before. It was -$0.01 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.13 | N/A |
| Dec 31, 2024 | -$1.66 | N/A |
| Dec 31, 2023 | -$1.50 | N/A |
| Dec 31, 2022 | -$0.19 | N/A |
| Dec 31, 2021 | -$0.02 | N/A |
| Dec 31, 2020 | -$0.01 | N/A |
Frequently Asked Questions About OBIO
When is Orchestra BioMed Holdings's next earnings date?
Orchestra BioMed Holdings's next earnings report is expected for Mar 10, 2027.
Did OBIO beat earnings estimates last quarter?
Yes. Orchestra BioMed Holdings reported EPS of -$0.30 for the quarter ended Sep 30, 2026, above the -$0.40 estimate, a 25.00% surprise.
What EPS do analysts expect from OBIO next quarter?
The consensus EPS estimate for Orchestra BioMed Holdings for the quarter ending Dec 31, 2026 is -$0.39 from 9 analysts, with estimates from -$0.40 to -$0.35.
How often does OBIO beat earnings estimates?
Orchestra BioMed Holdings beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +27.99%.
OBIO pages: Overview, Earnings, Forecast, Financials, Competitors